2020 tables: Institutions - Nature & Science - corporate

The 2020 tables are based on Nature Index data from 1 January 2019 to 31 December 2019.

Table criteria

# Institution Share 2018 Share 2019 Count 2019 Change in Adjusted Share 2018-2019*
1 IBM Corporation, United States of America (USA) 4.16 4.73 12 14.1%
2 Alphabet Inc., United States of America (USA) 4.88 3.83 8 -21.3%
3 Merck & Co., Inc., United States of America (USA) 4.43 1.94 8 -56.0%
4 Amgen Inc., United States of America (USA) 1.38 1.69 3 22.5%
5 Bristol-Myers Squibb (BMS), United States of America (USA) 0.93 0.98 3 4.8%
6 Johnson & Johnson, United States of America (USA) 0.69 0.86 1 25.8%
7 Arbor Biotechnologies, Inc., United States of America (USA) 0.83 1 N/A
8 Pfizer Inc., United States of America (USA) 1.48 0.60 5 -59.5%
9 Microsoft Corporation, United States of America (USA) 0.05 0.51 4 1,021.3%
10 Nimbus Therapeutics, United States of America (USA) 0.50 1 N/A
11 Leidos Holdings, Inc., United States of America (USA) 0.31 0.43 8 40.7%
12 Thermo Fisher Scientific Inc., United States of America (USA) 0.04 0.34 3 725.5%
13 Semma Therapeutics, Inc., United States of America (USA) 0.33 1 N/A
14 Schrödinger, LLC, United States of America (USA) 0.31 2 N/A
15 Nion Company, United States of America (USA) 0.30 1 N/A
16 Illumina, Inc., United States of America (USA) 0.35 0.30 3 -14.9%
17 Firebird Biomolecular Sciences, LLC, United States of America (USA) 0.28 1 N/A
18 Facebook, Inc., United States of America (USA) 0.25 1 N/A
19 ConfometRx, United States of America (USA) 0.24 1 N/A
20 Aduro BioTech, Inc., United States of America (USA) 0.02 0.22 2 997.7%
21 Analog Devices, Inc. (ADI), United States of America (USA) 0.21 1 N/A
22 Dyno Therapeutics, Inc., United States of America (USA) 0.21 1 N/A
23 AbbVie Inc., United States of America (USA) 0.07 0.20 1 180.9%
23 The MathWorks, Inc., United States of America (USA) 0.20 1 N/A
23 TRS Technologies, Inc., United States of America (USA) 0.20 1 N/A
24 10x Genomics, United States of America (USA) 0.19 3 N/A
25 KinetX Aerospace, Inc., United States of America (USA) 0.19 2 N/A
26 DNA Software Inc., United States of America (USA) 0.19 1 N/A
27 ICF International, Inc., United States of America (USA) 0.13 0.18 2 48.0%
28 Codexis, Inc., United States of America (USA) 0.17 1 N/A
29 Science Systems and Applications, Inc. (SSAI), United States of America (USA) 0.17 1 N/A
30 Bruker Corporation, United States of America (USA) 0.10 0.16 2 60.3%
31 EpiCypher, Inc., United States of America (USA) 0.16 1 N/A
32 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 0.14 1 N/A
33 23andMe, Inc., United States of America (USA) 0.00 0.14 2 3,894.1%
34 Optimized Markets, Inc., United States of America (USA) 0.13 1 N/A
34 Strategy Robot, Inc., United States of America (USA) 0.13 1 N/A
34 Strategic Machine, Inc., United States of America (USA) 0.13 1 N/A
34 Boulder Nonlinear Systems (BNS), United States of America (USA) 0.13 1 N/A
34 HyperLight Corporation, United States of America (USA) 0.13 1 N/A
35 Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.12 3 N/A
36 NeuroLux, Inc., United States of America (USA) 0.12 1 N/A
36 GenomeDx Biosciences US Headquarters and Clinical Laboratory, United States of America (USA) 0.12 1 N/A
36 Nervous System, Inc., United States of America (USA) 0.12 1 N/A
37 Protabit LLC, United States of America (USA) 0.11 1 N/A
38 Vedanta Biosciences, United States of America (USA) 0.11 1 N/A
39 General Motors (GM), United States of America (USA) 0.11 1 N/A
40 Hysitron, Inc., United States of America (USA) 0.10 2 N/A
41 Cayman Chemical Company, United States of America (USA) 0.10 1 N/A
41 Human Genome Project, United States of America (USA) 0.10 1 N/A
42 NGM Biopharmaceuticals, Inc., United States of America (USA) 0.09 1 N/A
43 Psyonic, Inc., United States of America (USA) 0.09 1 N/A
44 Bioqual, Inc., United States of America (USA) 0.05 0.09 2 84.1%
45 Biogen Inc., United States of America (USA) 0.06 0.09 1 41.9%
46 KBR Inc., United States of America (USA) 0.09 1 N/A
47 GeneDx Inc., United States of America (USA) 0.08 1 N/A
47 DLX Scientific, United States of America (USA) 0.08 1 N/A
47 ionQ, Inc., United States of America (USA) 0.08 2 N/A
47 AllyO, United States of America (USA) 0.08 1 N/A
48 Eureka Scientific, Inc., United States of America (USA) 0.04 0.08 2 117.4%
49 Rheos Medicines, United States of America (USA) 0.08 1 N/A
50 Disarm Therapeutics Inc., United States of America (USA) 0.07 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.